TRPV1/VR1 (extracellular) Blocking Peptide (#BLP-CC029) is the original antigen used for immunization during Anti-TRPV1 (VR1) (extracellular) Antibody (#ACC-029) generation. The blocking peptide binds and ‘blocks’ Anti-TRPV1/VR1 (extracellular) primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.